Cargando…
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
The microbiome is now regarded as one of the hallmarks of cancer and several strategies to modify the gut microbiota to improve immune checkpoint inhibitor (ICI) activity are being evaluated in clinical trials. Preliminary data regarding the upper gastro-intestinal microbiota indicated that Helicoba...
Autores principales: | Tonneau, Marion, Nolin-Lapalme, Alexis, Kazandjian, Suzanne, Auclin, Edouard, Panasci, Justin, Benlaifaoui, Myriam, Ponce, Mayra, Al-Saleh, Afnan, Belkaid, Wiam, Naimi, Sabrine, Mihalcioiu, Catalin, Watson, Ian, Bouin, Mickael, Miller, Wilson, Hudson, Marie, Wong, Matthew K., Pezo, Rossanna C., Turcotte, Simon, Bélanger, Karl, Jamal, Rahima, Oster, Paul, Velin, Dominique, Richard, Corentin, Messaoudene, Meriem, Elkrief, Arielle, Routy, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272833/ https://www.ncbi.nlm.nih.gov/pubmed/35832043 http://dx.doi.org/10.1080/2162402X.2022.2096535 |
Ejemplares similares
-
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota
por: Messaoudene, Meriem, et al.
Publicado: (2022) -
Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy
por: Diop, Khoudia, et al.
Publicado: (2023) -
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study
por: Tonneau, Marion, et al.
Publicado: (2023) -
Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case Series
por: Elkrief, Arielle, et al.
Publicado: (2021) -
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023)